Friday, May 09, 2008 Why choose Quintiles in Latin America? In Latin America we provide fully integrated services for Phase I-IV studies including central laboratory services and report writing for US and European (FDA, EMEA, and ICH-GCP) regulatory submissions. Access to patients is rapid, and is concentrated in general tertiary hospitals and a few specialty hospitals with which Quintiles has long-standing relationships. All of this makes Latin America a logical first choice for clinical trials. And we are the ones who make it work for you. For more information, please visit: http://www.quintilesimages.com/southamerica/ •   Osiris Therapeutics, Inc. (OSIR) and NuVasive, Inc. (NUVA) Enter into Definitive Agreement for Osteocel(R) for Up to $85 Million in Upfront and Milestone Payments More... •   Enzo Biochem (ENZ) Acquires BIOMOL International, Further Expanding Its Life Sciences Operations More... •   Applera Corporation (ABI)s Board of Directors Formally Approves Proposed Separation of Its Celera Business More... •   Spectrum Pharmaceuticals, Inc. (SPPI) Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals, Inc. More... •   Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) and Announces Subsequent Offering Period More... More Mergers and Acquisitions News •   Northwest Biotherapeutics (NWBT) Secures US$4.0 Million in Debt Financing More... More Finance News Latest Market Insight Drug Approval Trends at the FDA and EMEA Process improvements, heightened scrutiny and industry response • Delayed approvals. Regulators are requesting more data to validate or refute conclusions about product risks. This is creating a rise in the size and number of clinical trials as well as overall research budgets. • Rising R&D costs. Drug developers are continually increasing their R&D expenditures to generate approvable drug applications, despite rising financial pressures in the industry. Emerging technologies such as stem cells, genomics and proteomics are among the most prevalent initiatives being used to identify appropriate drug candidates. • US generics focus. The FDA is allocating resources to generic drug approvals in an attempt to speed these products to market. However, although Europe has recently developed a clear regulatory path for generic versions of biologicals, this is yet be achieved in the US. • Regulatory process improvements. Regulators are enhancing their drug review processes with new technologies such as electronic drug applications and technology-based standards for drug review. Click Here for More Information •   Hi-Tech Pharmacal (HITK) Launches Authorized Generic of Warner Chilcott's Dovonex(R) Scalp Solution More... •   Znomics, Inc. and University of Utah Launch Collaborative Drug Discovery Program in Oncology, Autoimmune Disease and Inflammation More... •   ABR–Affinity BioReagents Inks New Distribution Agreements in Switzerland and Hungary More... •   BioMS Medical (MS.TO) Provides Update On Pipeline Products - HYC750 Out-licensed to Orcrist More... More Alliances News •   Celator Pharmaceuticals, Inc. Announces Appointment of Scott Jackson as CEO More... •   AmerisourceBergen (ABC) Announces Streamlined Organization More... •   Ardea Biosciences, Inc. Appoints John W. Beck Chief Financial Officer More... •   DOR BioPharma, Inc. (DORB) Announces Appointment of Christopher J. Schaber, PhD, to Board of Directors of the Alliance for BioSecurity More... More Personnel News •   Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Second Quarter Fiscal Year 2008 Financial Results More... •   Acusphere Inc. (ACUS) Reports Q1 2008 Financial Results and Business Highlights More... •   Alnylam Pharmaceuticals (ALNY) Reports First Quarter 2008 Financial Results More... •   Affymax, Inc. (AFFY) Reports First Quarter 2008 Financial Results More... •   Ambrilia Biopharma Inc.: Conference Call and Webcast for First Quarter 2008 Results More... More Earnings Report News •   Shire Pharmaceuticals Group plc (SHPGY) Results of Court Meeting and Extraordinary General Meeting; Shareholders Approve Scheme of Arrangement and New Share Plans More... More Legal News   Property for Sale 101 Mettlers Road Somerset, New Jersey U.S.A. • BUILDINGS: Four interconnected office, research and development buildings • Versatile lay-out divides for multi-tenant scenarios. • 49.2 acres of undeveloped surplus land, which can be used to expand the existing facility or other development opportunities. More Real Estate Listings Hot Company Rho, Inc. 6330 Quadrangle Drive Suite 500 Chapel Hill, North Carolina 27517 U.S.A. Phone: 919-408-8000 or (888) RHO-DATA Fax: 919-408-0999 View Jobs Repeat business speaks for itself. At Rho, Inc. we value the loyal relationships of our customers, who rely on us to swiftly ready new products for market. Rho is a full-service clinical research organization dedicated to enhancing the quality and speed of their customers' clinical trials. Rho provides high quality and timely services in the design, development, and execution of all phases of clinical research. Rho has contributed to the success of pharmaceutical and biotech studies in a wide range of therapeutic areas since 1984. More Company Profiles DIA Annual Convention: Join more than 8,000 attendees as they share information about the latest innovations in drug development and search for solutions to industry challenges. Highlights of this year's event: • Over 360 sessions across 26 content areas • 40 preconference tutorials • Over 1000 speakers, including representatives from FDA, EMEA, and other global regulatory agencies • 500+ exhibiting companies • Networking Reception at the Boston Museum of Science Please click here for more information. More Investor Events More Business Development Events  • Genetown (Cambridge, Massachusetts) Hot Job of the Day: Novartis Institutes for BioMedical Research, Inc. Senior Business & Planning Analyst Leading the planning and allocation of resources to countries, departments, and projects. Preparing analysis to support decision making of department heads with responsibility for implementing agreed financial action plans accordingly. • Biotech Bay (San Francisco, California) Hot Job of the Day: Medivation, Inc. Director, Oncology Marketing The Director will be responsible for optimizing commercial development for a novel compound for hormone-refractory prostate cancer currently in Phase II trials. He or she will also serve as the product champion within the Company. • Biotech Beach (Orange County, California) Hot Job of the Day: Integrium Director of Business Development - West Coast The Business Development Director is responsible for securing new business from pharmaceutical, biotech, and device companies within Integrium’s target market in the assigned territory. • Bio NC (Morrisville, North Carolina) Hot Job of the Day: Schering-Plough Corporation Director, Commercial Development Manage the customers and sales process from initial contact through the signing of a contract by using all tools at their disposal including involving senior management, marketing and sales support. • Pharm Country (Upper Gwynedd, Pennsylvania) Hot Job of the Day: Smith Hanley Consulting Group Medical Program Financial Specialist II Support the financial management of IISP by developing and maintaining a direct working relationship with the Global Research Specialists, Company Financial Specialist Administrator, paralegals, finance departments, Company subsidiary offices and external customers. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! New BioSpace White Paper! Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Read it Now! We are pleased to present the BioSpace Career Fair in Pharm Country on Thursday, June 5, 2008 at the Hanover Marriott in Whippany, NJ. BioSpace Career Fairs give job seekers the opportunity to meet face-to-face with the region's elite science industry employers while presenting the opportunity to interview for hundreds of specialized open positions. CLICK Here to submit your resume for the Pharm Country Career Fair now! Qualified candidates will receive their invitations and confirmation numbers via email 24 to 48 hours after their resumes have been submitted. Pre-screened and accepted candidates must bring a copy of their invitation with confirmation number to the event. We look forward to seeing you at the Pharm Country Career Fair! • Pharm Country Career Fair, June 5, 2008 • DDT - BioSpace 2008 Career Fair, August 6, 2008 • DeviceSpace Career Fair, September 8, 2008 • BioCapital Career Fair, September 30, 2008 • Biotech Bay Career Fair, October 14, 2008 More information about BioSpace's Career Fairs If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the BioSpace Deals & Dollars here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here or by clicking on the "unsubscribe" link at the bottom of this newsletter.  Send questions and comments to the BioSpace NewsBeat Team • Post your News • Post your Jobs • Post your Company Profile • Post your Event • Advertising/Sponsorship East Coast Office: BioSpace, Inc. Ramshorn Executive Centre 2399 Highway 34, Building A-5 Manasquan, New Jersey 08736-1528 U.S.A. Phone: 732-528-3688 Fax: 732-528-3668 West Coast Office: BioSpace, Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Editor & Publisher: Rosemary Do Editorial & Production Staff: Annalyn Aquino Suvarna Bhatt Lana Ho BioSpace.com - Where Life Sciences Thrive. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2008 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.